Abstract
The present disclosure provides novel compounds derived from docosahexaenoic acid endocannabinoid epoxides having anti-cancer, anti-inflammatory, anti-platelet aggregation and anti-angiogenic properties. Methods of synthesizing and using the compositions are also provided.
| Original language | English (US) |
|---|---|
| U.S. patent number | 11472787 |
| Filing date | 9/20/18 |
| State | Published - Oct 18 2022 |